Blanco-Colio LM - Search Results

1

Low-density lipoprotein cholesterol and high-sensitivity C-reactive protein lowering with atorvastatin in patients of South Asian compared with European origin: insights from the Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST) study.

Gupta M, Martineau P, Tran T, Després JP, Gaw A, de Teresa E, Farsang C, Gensini GF, Leiter LA, Blanco-Colio LM, Egido J, Langer A; ACTFAST investigators. Gupta M, et al. J Clin Pharmacol. 2012 Jun;52(6):850-8. doi: 10.1177/0091270011407196. Epub 2011 May 24. J Clin Pharmacol. 2012. PMID: 21610204 Clinical Trial.

2

3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.

Blanco-Colio LM, Villa A, Ortego M, Hernández-Presa MA, Pascual A, Plaza JJ, Egido J. Blanco-Colio LM, et al. Atherosclerosis. 2002 Mar;161(1):17-26. doi: 10.1016/s0021-9150(01)00613-x. Atherosclerosis. 2002. PMID: 11882313

3

Anti-inflammatory and immunomodulatory effects of statins.

Blanco-Colio LM, Tuñón J, Martín-Ventura JL, Egido J. Blanco-Colio LM, et al. Kidney Int. 2003 Jan;63(1):12-23. doi: 10.1046/j.1523-1755.2003.00744.x. Kidney Int. 2003. PMID: 12472764 Free article. Review.

4

3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes.

Blanco-Colio LM, Muñoz-García B, Martín-Ventura JL, Lorz C, Díaz C, Hernández G, Egido J. Blanco-Colio LM, et al. Circulation. 2003 Sep 23;108(12):1506-13. doi: 10.1161/01.CIR.0000089086.48617.2B. Epub 2003 Sep 2. Circulation. 2003. PMID: 12952848

5

Statins to prevent cardiovascular events in hypertensive patients. The ASCOT-LLA study.

Osende JI, Ruiz-Ortega M, Blanco-Colio LM, Egido J. Osende JI, et al. Nephrol Dial Transplant. 2004 Mar;19(3):528-31. doi: 10.1093/ndt/gfg538. Nephrol Dial Transplant. 2004. PMID: 14767002 Review. No abstract available.

6

Decreased circulating Fas ligand in patients with familial combined hyperlipidemia or carotid atherosclerosis: normalization by atorvastatin.

Blanco-Colio LM, Martín-Ventura JL, Sol JM, Díaz C, Hernández G, Egido J. Blanco-Colio LM, et al. J Am Coll Cardiol. 2004 Apr 7;43(7):1188-94. doi: 10.1016/j.jacc.2003.10.046. J Am Coll Cardiol. 2004. PMID: 15063428 Free article. Clinical Trial.

7

[Statins, inflammation and atherosclerotic damage].

Blanco-Colio LM, Martín-Ventura JL, Gómez-Hernández A, Egido J. Blanco-Colio LM, et al. Nefrologia. 2004;24 Suppl 4:17-20. Nefrologia. 2004. PMID: 15279380 Free article. Spanish. No abstract available.

8

Intensive treatment with statins and the progression of cardiovascular diseases: the beginning of a new era?

Tuñón J, Blanco-Colio LM, Martín-Ventura JL, Egido J. Tuñón J, et al. Nephrol Dial Transplant. 2004 Nov;19(11):2696-9. doi: 10.1093/ndt/gfh472. Epub 2004 Aug 31. Nephrol Dial Transplant. 2004. PMID: 15340095 Review. No abstract available.

9

Statins in hypertensive patients: potential explanations for the ASCOT-LLA study results.

Blanco-Colio LM, Osende JI, Martín-Ventura JL, Tuñón J, Egido J. Blanco-Colio LM, et al. Drugs. 2004;64 Suppl 2:61-7. doi: 10.2165/00003495-200464002-00006. Drugs. 2004. PMID: 15765891 Review.

10

Inflammatory biomarkers and statins.

Blanco-Colio LM, Tuñón J, Martín-Ventura JL, Egido J. Blanco-Colio LM, et al. Drugs Today (Barc). 2005 Mar;41(3):171-7. doi: 10.1358/dot.2005.41.3.892522. Drugs Today (Barc). 2005. PMID: 15883614 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters